These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 6457625

  • 1. Antibodies against platelet membrane glycoproteins. II. Influence on ADP- and collagen-induced platelet aggregation, crossed immunoelectrophoresis studies and relevance to Glanzmann's thrombasthenia.
    Jenkins CS, Ali-Briggs EF, Clemetson KJ.
    Br J Haematol; 1981 Nov; 49(3):439-47. PubMed ID: 6457625
    [Abstract] [Full Text] [Related]

  • 2. Monocytes and platelets share the glycoproteins IIb and IIIa that are absent from both cells in Glanzmann's thrombasthenia type I.
    Gogstad G, Hetland O, Solum NO, Prydz H.
    Biochem J; 1983 Aug 15; 214(2):331-7. PubMed ID: 6225428
    [Abstract] [Full Text] [Related]

  • 3. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H, McGregor JL.
    Eur J Biochem; 1988 Jan 15; 171(1-2):383-92. PubMed ID: 3338471
    [Abstract] [Full Text] [Related]

  • 4. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
    Hardisty R, Pidard D, Cox A, Nokes T, Legrand C, Bouillot C, Pannocchia A, Heilmann E, Hourdillé P, Bellucci S.
    Blood; 1992 Aug 01; 80(3):696-708. PubMed ID: 1638023
    [Abstract] [Full Text] [Related]

  • 5. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S, Kornecki E, Hershock D, Tuszynski GP, Bennett JS, Soria C, Soria J, Dunn F, Pidard D, Kieffer N.
    J Lab Clin Med; 1985 Dec 01; 106(6):651-60. PubMed ID: 2999274
    [Abstract] [Full Text] [Related]

  • 6. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa.
    McGregor L, Hanss M, Sayegh A, Calvette JJ, Trzeciak MC, Ville D, Catimel B, Viala JJ, Dechavanne M, McGregor JL.
    Thromb Haemost; 1989 Nov 24; 62(3):962-7. PubMed ID: 2595666
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies against human platelet glycoprotein IIIa.
    Tetteroo PA, Lansdorp PM, Leeksma OC, von dem Borne AE.
    Br J Haematol; 1983 Nov 24; 55(3):509-22. PubMed ID: 6227332
    [Abstract] [Full Text] [Related]

  • 8. Involvement of divalent cations in the complex between the platelet glycoproteins IIb and IIIa.
    Hangen I, Bjerrum OJ, Gogstad G, Korsmo R, Solum NO.
    Biochim Biophys Acta; 1982 Feb 04; 701(1):1-6. PubMed ID: 6173070
    [Abstract] [Full Text] [Related]

  • 9. Antibodies against platelet membrane glycoproteins. I. Crossed immunoelectrophoresis studies with antibodies that inhibit ristocetin-induced platelet aggregation.
    Ali-Briggs EF, Clemetson KJ, Jenkins CS.
    Br J Haematol; 1981 Jun 04; 48(2):305-18. PubMed ID: 7236528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
    Fournier DJ, Kabral A, Castaldi PA, Berndt MC.
    Thromb Haemost; 1989 Nov 24; 62(3):977-83. PubMed ID: 2512684
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
    Kornecki E, Tuszynski GP, Niewiarowski S.
    J Biol Chem; 1983 Aug 10; 258(15):9349-56. PubMed ID: 6308003
    [Abstract] [Full Text] [Related]

  • 13. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.
    McEver RP, Bennett EM, Martin MN.
    J Biol Chem; 1983 Apr 25; 258(8):5269-75. PubMed ID: 6220015
    [Abstract] [Full Text] [Related]

  • 14. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT, Rosa JP, Fournier D, Legrand C, Didry D, Parquet A, Pidard D.
    J Clin Invest; 1987 Mar 25; 79(3):962-9. PubMed ID: 3818957
    [Abstract] [Full Text] [Related]

  • 15. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS, Peerschke EI, Seligsohn U, Scudder LE, Nurden AT, Rosa JP.
    J Lab Clin Med; 1986 Apr 25; 107(4):384-92. PubMed ID: 2420911
    [Abstract] [Full Text] [Related]

  • 16. Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type I and type II.
    Lee H, Nurden AT, Thomaidis A, Caen JP.
    Br J Haematol; 1981 May 25; 48(1):47-57. PubMed ID: 6454435
    [Abstract] [Full Text] [Related]

  • 17. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation.
    Stricker RB, Wong D, Shiu DT, Reyes PT, Shuman MA.
    Blood; 1986 Jul 25; 68(1):275-80. PubMed ID: 2941084
    [Abstract] [Full Text] [Related]

  • 18. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
    Coller BS, Peerschke EI, Scudder LE, Sullivan CA.
    J Clin Invest; 1983 Jul 25; 72(1):325-38. PubMed ID: 6308050
    [Abstract] [Full Text] [Related]

  • 19. Effect of the binding of anti-Zwa antibodies on platelet function.
    van Leeuwen EF, Leeksma OC, van Mourik JA, Engelfriet CP, von dem Borne AE.
    Vox Sang; 1984 Jul 25; 47(4):280-9. PubMed ID: 6548327
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.